Skip to main content

Find Clinical Trials

Home
Conditions
COVID 19 Associated Coagulopathy

Clinical trial condition

COVID 19 Associated Coagulopathy

Explore clinical trials studying COVID 19 Associated Coagulopathy. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

COVID 19 Associated Coagulopathy trial results

Recruiting

A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

NCT06355258

Conditions: COVID 19 Associated Coagulopathy
Locations: Shaoxing central hospital Shaoxing, Zhejiang, China

View Trial Details

Not Yet Recruiting

Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism

NCT06992401

Conditions: Behavior, Behavioral Symptoms, COVID 19 Associated Coagulopathy, +26 more
Locations: Not specified

View Trial Details

Completed

Covid-19 Associated Coagulopathy

NCT04360824

Conditions: COVID 19 Associated Coagulopathy
Locations: University of Iowa Iowa City, Iowa, United States

Gundersen Health System La Crosse, Wisconsin, United States

View Trial Details

Completed

Prevalence of Thrombophilic Gene Polymorphism (MTHFR C677T) in COVID-19patients

NCT05679414

Conditions: COVID 19 Associated Coagulopathy
Locations: Ain Shams University Cairo, Egypt

View Trial Details

Completed

Coagulation Disturbances in COVID-19 Septic Patients

NCT05496816

Conditions: COVID 19 Associated Coagulopathy, Cardiovascular Diseases, Coagulation Disorder, +14 more
Locations: Cantonal Hospital Zenica, Bosnia and Herzegovina

View Trial Details